Compugen Cash Flow per Share
The Operating Cash Flow per Share of Compugen (CGEN) as of Sep 14, 2026 is 0.33 USD. In the previous year, Operating Cash Flow per Share was 0.55 USD — a change of -39.71% (lower).
Get this data via API
Financial Data API
Cash Flow per Share
0.33USD
YoY
-39.71%
Last updated:
Operating Cash Flow per Share of Compugen is 2026 0.33 USD. Operating Cash Flow per Share of Compugen was 2025 0.55 USD. It decreases by -39.71% lower compared to the previous year.
The Compugen Cash Flow per Share history
3 Years
10 Years
25 Years
Max
Cash Flow per Share
Date
Cash Flow per Share
Jan 1, 2018
-0.22 USD
Jan 1, 2019
-0.41 USD
Jan 1, 2020
-0.34 USD
Jan 1, 2021
-0.27 USD
Jan 1, 2022
-0.39 USD
Jan 1, 2023
-0.41 USD
Jan 1, 2024
0.55 USD
Jan 1, 2025
0.33 USD
| YEAR | Cash Flow per Share | YoY |
|---|---|---|
| 0.33USD | -39.71% | |
| 0.55USD | -236.49% | |
| -0.41USD | +3.07% | |
| -0.39USD | +48.14% | |
| -0.27USD | -21.49% | |
| -0.34USD | -17.88% | |
| -0.41USD | +84.70% | |
| -0.22USD | -62.66% | |
| -0.60USD | +53.95% | |
| -0.39USD | -23.39% | |
| -0.51USD | +127.96% | |
| -0.22USD | — |
Access this data via the Eulerpool API
Compugen Stock analysis
What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Compugen stock
Operating Cash Flow per Share of Compugen is 0.33 USD in 2026.
Operating Cash Flow per Share of Compugen changed from 0.55 USD to 0.33 USD, representing a -39.71% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Operating Cash Flow per Share Compugen since 2006 – with annual values, charts, and detailed analysis.
Operating cash flow per share measures the operating cash generated per outstanding share.
Access this data via the Eulerpool API
Cash Flow — Compugen
Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A
All Key Metrics — Compugen
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth